Key facts
- It has raised $1.0M; the latest was Later Stage VC ($1.0M) in Mar 2025.
- Notable investors include Vento, Club degli investitori, Panakes Partners, Simon Fiduciaria, Accelerate in Israel — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Relief
- ·The full record, as it builds
Funding rounds
No funding rounds for Relief are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Relief
Developer of an endo-urethral sphincter designed to treat stress urinary incontinence. The company offers a product that is a unisex, invasive endo-urethral magnetic device that can be replaced in an outpatient setting, and the device can completely restore urination control, even in patients suffering from severe stress urinary incontinence forms, enabling patients to get effective and low-cost treatment.
- Sector
- Healthcare
- HQ
- Pontedera, Italy
- Founded
- 2019
- Employees
- 3
- Website
- reliefsrl.com/
- Ownership
- Privately Held (backing)
Relief doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Relief shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Relief in its N-PORT filings yet. We sweep new filings monthly.